WISECAP Study
Not Applicable
Recruiting
- Conditions
- Tuberculosis
- Registration Number
- PACTR202205876377808
- Lead Sponsor
- Infectious Diseases Institute Makerere University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 164
Inclusion Criteria
1.Newly diagnosed patient of pulmonary MDR-TB and or Rifampicin resistant TB aged 8 years and above.
2.Patients being initiated on the oral MDR-TB treatment
3.Evidence of a personally signed and dated informed consent document (or a legal representative).
Exclusion Criteria
1. Patients with any condition that inhibits the use of the MEMS device e.g. dexterity or debilitating arthritis.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall adherence rates among MDR-TB patients on self-administered therapy and on DOT
- Secondary Outcome Measures
Name Time Method 1.Correlation between serum MDR_TB drug concentrations and adherence data for patients on self-administered therapy and DOT ;Sputum conversion ;MDR-TB outcomes (cure, treatment completion, loss to follow-up or death) in each arm